LANTERN PHARMA INC.

Insiders Lantern Pharma Inc.

Equities

LTRN

US51654W1018

Market Closed - Nasdaq Other stock markets 21:00:00 14/05/2024 BST			5-day change	1st Jan Change
6.19 ^USD	+1.64%		-3.58%	+44.63%

05-09	Transcript : Lantern Pharma Inc., Q1 2024 Earnings Call, May 09, 2024
05-09	Lantern Pharma Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lantern Pharma Inc. Announces the Death of Dr. Franklyn Prendergast, a Director of the Company	20/10/23	CI
Lantern Pharma Inc. Appoints Ernest Kitt as Head of Clinical Operations	02/03/23	CI
Insider Sell: Lantern Pharma	10/11/22	MT
Lantern Pharma Inc. Announces Leslie W. Kreis, Jr. Not to Stand for Reelection as A Director	26/04/22	CI
Lantern Pharma Appoints Harry Kochat as Senior Director of Chemistry, Manufacturing and Controls and Manufacturing Quality Affair	02/09/21	CI
Lantern Pharma Inc. Announces Executive Changes	17/12/19	CI
Lantern Pharma Announces Board Appointments	11/12/19	CI
Lantern Pharma Inc. Appoints Jeff Keyser to its Board of Directors	09/01/17	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

As early as today, start finding the best investment opportunities!

Optimize my profits

fermer